Target intelligence / Profile preview

RNA, 5S ribosomal pseudogene 417 (RNA5SP417)

Target
RNA5SP417
Molecular classification
Pseudogene, Non-coding RNA, rRNA pseudogene
01

Overview

RNA, 5S ribosomal pseudogene 417 (RNA5SP417) is classified as a **pseudogene**, meaning it is a genetic sequence similar to a functional gene for 5S ribosomal RNA but contains mutations or deletions preventing it from code for a functional product[2][6][7]. Pseudogenes arise via duplication or retrotransposition of functional genes in evolution, but generally lose their original function and are considered “genomic fossils”[4][6]. In rare cases, pseudogenes can regulate gene expression, e.g., acting as competitive endogenous RNAs, but there is no evidence for functional activity or disease relevance for RNA5SP417 itself[4]. Pseudogenes like RNA5SP417 are not targeted by drugs and are not involved in canonical cellular processes or therapeutic pathways[2][7].

Other names
RN5S417RNA, 5S ribosomal 417RNA5SP417
02

Mechanism of action

None (not a functional or therapeutic target)

03

Biological functions

Does not have a direct biological function; pseudogenes may, in rare cases, act as competitive endogenous RNAs (ceRNAs), but no functional role is established for RNA5SP417 specifically
04

Disease associations

None established for RNA5SP417In general, pseudogenes can sometimes impact gene regulation in cancer and other diseases, but RNA5SP417 has no known role
05

Safety considerations

None (not druggable or targetable)
06

Interacting drugs

None (as a pseudogene, it does not interact with drugs)
07

Biomarkers

None established

Beyond the preview

Go deeper on RNA, 5S ribosomal pseudogene 417 (RNA5SP417).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 5S ribosomal pseudogene 417 (RNA5SP417).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call